Clinical trial
Hypoplastic Left Heart Syndrome: Subendocardial Viability After Norwood Palliation
NCT05709275 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypoplastic Left Heart Syndrome: Subendocardial Viability After Norwood Palliation
- Lead sponsor
- IRCCS Policlinico S. Donato
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 28, 2022
- Completion date
- September 30, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.